Therapeutic-area Dossier
Hepatology
Therapeutic-area Dossier for Hepatology (liver medicines). Australian brands, active ingredients, PBS-listed treatments, PBAC outcomes — compiled by…
- Brand: ENTECAVIR SANDOZ
- Brand: IQIRVO
- Brand: OCALIVA
- Brand: PEGASYS
- Brand: URSODOX
- Brand: URSOFALK
- Sponsor: Arrotex Pharmaceuticals
- Sponsor: Gilead Sciences
- Sponsor: Bayer
- Sponsor: FIT-BioCeuticals
What is
Hepatology Hepatology covers therapeutic products related to liver disease and function, with 16 brands registered in this area.
Brands registered in Hepatology The top brands registered in Hepatology are:
— OCALIVA — VOSEVI — ACETYLCYSTEINE-LINK — HEPATOLITE — PRIMOVIST
Sponsor landscape
The Hepatology area has 15 active sponsors. Top sponsors include FIT-BioCeuticals, Link Medical Products Pty Ltd T/A Link Pharmaceuticals, Auland Biotech Pharmaceuticals, Musashi, Global Medical Solutions Australia Pty Limited T/A Radpharm Scientific, Greenfield Pharmaceutical, Achieve Correctness (Australia) Company Proprietary, and Ausus Bio Health.
PBS and regulatory activity
One brand in Hepatology has PBS-listed items, with the latest PBS schedule date being 1 May 2026. Two brands have PBAC outcomes on record, with the latest PBAC outcome dated 1 March 2021. One brand has an AusPAR on record, with the latest AusPAR dated 13 March 2018.